Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 1
2005 2
2006 1
2007 1
2008 3
2009 5
2010 6
2011 5
2012 2
2013 3
2014 8
2015 6
2016 6
2017 4
2018 1
2019 3
2020 8
2021 5
2022 7
2023 17
2024 6
2025 9
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal Computed Tomographic Evaluation of Mandibular Bone Morphology Following OnabotulinumtoxinA Treatment of Masseter Muscle Prominence: Results of a 12-Month, Repeat-Treatment, Placebo-Controlled Study in Healthy Adults.
Mallya SM, Kostenuik P, Hopfinger R, Ahmad M, Mah J, Gonzalez S, Faletto D, Lee E, Bowen B, Mccaskill R, Brin MF. Mallya SM, et al. Among authors: brin mf. Aesthet Surg J. 2026 Apr 24:sjag080. doi: 10.1093/asj/sjag080. Online ahead of print. Aesthet Surg J. 2026. PMID: 42035242 Free article.
OnabotulinumtoxinA Treatment for Masseter Muscle Prominence: 6-Month Safety and Efficacy Results, Including Patient-Reported Outcomes, From a Phase 3, Randomized, Placebo-Controlled, Multiregional Trial.
Sun J, Wang L, Wu Y, Humphrey S, Chen SG, McGillivray W, Huang SH, Zhang Y, Pan G, Foley C, Lee E, Chang-Lin JE, Faletto DL, Patel V, Bowen B, Brin MF. Sun J, et al. Among authors: brin mf. Aesthet Surg J. 2026 Apr 7;46(5):486-494. doi: 10.1093/asj/sjaf204. Aesthet Surg J. 2026. PMID: 41092464 Free PMC article. Clinical Trial.
OnabotulinumtoxinA for the preventive treatment of episodic migraine: Results from the phase 3, multicenter randomized, double-blind, placebo-controlled phase of the PRECLUDE trial.
Pozo-Rosich P, Blumenfeld AM, Lipton RB, DeGryse RE, Li B, Adams AM, Nguyen T, James L, Brin MF. Pozo-Rosich P, et al. Among authors: brin mf. Cephalalgia. 2025 Oct;45(10):3331024251370769. doi: 10.1177/03331024251370769. Epub 2025 Oct 15. Cephalalgia. 2025. PMID: 41091731 Free article. Clinical Trial.
Longitudinal Computed Tomography Indicates No Negative Impact of OnabotulinumtoxinA on Mandibular Bone Density in a 12-Month, Double-Blind, Randomized, Repeat Treatment, Placebo-Controlled Study in Healthy Adults With Masseter Muscle Prominence.
Kostenuik P, Mallya SM, Hopfinger R, Aghaloo T, Gonzalez S, Mah J, Ahmad M, Pan G, Faletto DL, Lee E, Bowen B, Brin MF. Kostenuik P, et al. Among authors: brin mf. Aesthet Surg J. 2025 Dec 16;46(1):76-85. doi: 10.1093/asj/sjaf167. Aesthet Surg J. 2025. PMID: 40843518 Free PMC article. Clinical Trial.
107 results